Primary adrenal lymphoma: a case series study

Abstract

Dear Editor, Non-Hodgkin’s lymphoma affects the adrenal gland, usually in the advanced stage of the disease. In 30% to 50% of patients with primary adrenal lymphoma (PAL), there are signs compatible with subclinical adrenal insufficiency only detected by laboratory tests [2, 3]. Autopsy series show that 25% of patients present gland involvement, in some degree, during disease course [1]. PAL is a rare form of primary adrenal neoplasia, and the Englishlanguage medical literature has reported 70 cases of PAL; the Chinese has only 30 cases [3]. We had three cases, and they will be presented below. Case 1: An 80-year-old man, reporting abdominal pain, nausea, and loss of weight for 5 months. Physical examination: pale, hyperpigmentation of the skin, and cardiac arrhythmia. Abdominal magnetic resonance imaging: ovalshaped bilateral mass of the adrenal gland, swollen on its left side (5.5 cm). Laboratory tests: Table 1. The patient started glucocorticoid and mineralocorticoid therapy and went through CHOP chemotherapy regimen (cyclophosphamide, Adriamycin or hydroxydoxorubicin, vincristine, and prednisone) associated to rituximab. The clinical outcome was the patient’s death due to respiratory failure 2 months after the diagnosis. Case 2: A 62-year-old man presenting a history of asthenia, anorexia, loss of weight, postural hypotension for 6 months, associated with severe abdominal pain. Physical examination: blood pressure 110×80 mmHg (seating) and 80×70 mmHg (standing); ungual hyperpigmentation. Insulin resistance test with no cortisol enhancement; abdominal tomography: bilateral mass lesions of the adrenal gland, swollen on its right side (10 cm), with renal capsule invasion. Laboratory tests: Table 1. He started chemotherapy but died 6 months after due to pulmonary thromboembolism. Case 3: A 73-year-old woman, with diabetes, reporting hypoglycemia and decreased consciousness, using chlorpropramide. After having discontinued medication, she presented hyponatremia and hypoglycemia over 7 days (drug half-life). Physical examination showed disorientation and obnubilation. Laboratory exams disclosed bicytopenia (Table 1). Under suspicion of hematological neoplasia, she had an abdominal tomography that disclosed bilateral diffuse adrenal hyperplasia. She started chemotherapy associated with corticotherapy, making the full endocrine investigation impossible. The glycemic level and the natremia were normalized. Currently, the patient is under chemotherapy regimen (CHOP and rituximab) with a 14-month survival. Literature indicates that adrenal insufficiency is the most common clinical manifestation of PAL cases [5, 6] identified in the first two reported cases. Regarding case 3, unfortunately, there has not been enough time to make a more detailed investigation. Case 1 presented elevated serum levels of adrenocorticotropic hormone (ACTH), upholding the presence of skin hyperpigmentation. All the studied cases presented low levels of dehydroepiandrosterones (DHEAs), not confirming adrenal carcinoma. The radiological investigation of the three cases pointed out bilateral and heterogeneous images, which are the most typical forms described in literature. The fine-needle aspiraAnn Hematol (2008) 87:859–861 DOI 10.1007/s00277-008-0492-x